Fluconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Fluconazole Prices June 2023
|
Product
|
Category | Region | Price |
|---|---|---|---|
| Fluconazole | Pharma API | USA | 165,223 USD/MT |
| Fluconazole | Pharma API | China | 171,770 USD/MT |
| Fluconazole | Pharma API | Germany | 172,663 USD/MT |
In June 2023, the prices of fluconazole reached 165,223 USD/MT in the United States. Whereas the price of fluconazole in China for Q2 2023 reached 171,770 USD/MT in June. Similarly, the price of fluconazole in Germany for Q2 2023 reached 172,663 USD/MT in June.
Fluconazole Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Fluconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of fluconazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of fluconazole at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of fluconazole price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing fluconazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Fluconazole Market Analysis
The global fluconazole market size reached US$ 273 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 365.7 Million, at a projected CAGR of 3.30% during 2023-2032.
- Fluconazole is becoming increasingly popular in the pharmaceutical sector as a critical component for managing invasive infections, which are significant in hospital settings.
- The stricter environmental laws, which have led to a greater use of fluconazole due to its efficacy and broad spectrum antifungal activity, are augmenting the market share.
- The fluconazole demand is further amplified by its utilization as a treatment in healthcare sectors for fungal infections, prevalent in immunocompromised patients such as those undergoing chemotherapy or with AIDS.
- The market share is further being reinforced by the development of advanced formulations that enhance its solubility and patient compliance.
- Another factor driving fluconazole consumption across the globe is the growing government support for its use in public health programs through subsidies and inclusion in essential medicines lists.
- In addition, fluconazole production is showing an upward trajectory as a result of its growing use in combating emerging fungal infections and resistance, supporting the need for effective antifungal agents.
- The market share is also expanding due to fluconazole's increased demand in healthcare sectors, owing to the rise in fungal infection rates driven by global increases in immunocompromised populations.
- Fluconazole production has also witnessed a considerable surge due to widespread investment in the pharmaceutical sector, aiming at expanding the reach of essential medicines.
- The market is also expanding due to technological developments in drug delivery systems that are raising overall treatment efficacy and lowering side effects, which results in competitive pricing.
- A positive trend for the market is also being created by the increased use of fluconazole in various therapeutic regimes due to its favorable safety profile, making it a preferred choice for long-term therapy.
Fluconazole News
The report covers the latest developments, updates, and trends impacting the global fluconazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in fluconazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the fluconazole price trend.
Latest developments in the fluconazole industry:
- May 16, 2024: Arvinas, Inc. and Pfizer Inc. released updated clinical data from a Phase 1b study of vepdegestrant combined with palbociclib, showing continued promising results in patients with advanced ER+/HER2- breast cancer. The findings, which align with previous reports from the December 2023 SABCS, were presented at the 2024 ESMO Breast Cancer Annual Congress.
- May 1, 2024: Bayer, a leading global life sciences company, and Huma Therapeutics Limited, a leading global digital health company, announced the launch of their innovative heart health screening tool in Saudi Arabia. This marks the first global launch since the Bayer Aspirin Heart Health Risk Assessment went live in the US in 2023, and is aimed at supporting key objectives of the Vision 2030 national strategy for Saudi Arabia.
Product Description
Fluconazole belongs to the group of triazole antifungals. The traditional name commonly used for promotion is Diflucan. The medication is utilized in treating fungal infections that can impact various body parts such as the mouth, throat, esophagus, lungs, bladder, genital area, and even the bloodstream. Fluconazole blocks the production of ergosterol, an important component of the fungal cell membrane.
Without ergosterol, the fungal cell's membrane will not be built correctly, increasing its permeability and resulting in its death. Fluconazole blocks the action of the enzyme cytochrome P450 14α-demethylase, involved in the synthesis of ergosterol. It can reach levels in cerebrospinal fluid similar to those in plasma, and has fewer side effects compared to other antifungals, making it a reliable option for both immunocompetent and immunocompromised individuals.
Regional Coverage
The report provides a detailed analysis of the fluconazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the fluconazole price trend.
Global Fluconazole Price
The report offers a holistic view of the global fluconazole pricing trends in the form of fluconazole price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of fluconazole but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed fluconazole demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Fluconazole Price
European fluconazole prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed fluconazole price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Fluconazole Price
The analysis of fluconazole prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific fluconazole historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Fluconazole Price
The report explores the fluconazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on fluconazole prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Fluconazole Price
The fluconazole pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This fluconazole price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Fluconazole Price
The analysis of fluconazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Fluconazole |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Fluconazole Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of fluconazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting fluconazole price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The fluconazole price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Inquire Before Buying
Speak to an Analyst
Request Brochure
Request Customization
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
